SK Bioscience Co Ltd - Asset Resilience Ratio

Latest as of September 2025: 28.99%

SK Bioscience Co Ltd (302440) has an Asset Resilience Ratio of 28.99% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read 302440 total debt and obligations for a breakdown of total debt and financial obligations.

Liquid Assets

₩847.30 Billion

≈ $574.20 Million USD Cash + Short-term Investments

Total Assets

₩2.92 Trillion

≈ $1.98 Billion USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2018–2024)

This chart shows how SK Bioscience Co Ltd's Asset Resilience Ratio has changed over time. See what is SK Bioscience Co Ltd's book value for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down SK Bioscience Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see SK Bioscience Co Ltd stock valuation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩847.30 Billion	28.99%
Total Liquid Assets	₩847.30 Billion	28.99%

Asset Resilience Insights

Very High Liquidity: SK Bioscience Co Ltd maintains exceptional liquid asset reserves at 28.99% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

SK Bioscience Co Ltd Industry Peers by Asset Resilience Ratio

Compare SK Bioscience Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	3.28%
Summit Therapeutics PLC NASDAQ:SMMT	Biotechnology	0.00%
Argen-X F:1AE	Biotechnology	25.67%
Zhejiang Ausun Pharmaceutical Co Ltd SHG:603229	Biotechnology	0.21%
R&G PharmaStudies Co. Ltd. A SHE:301333	Biotechnology	35.96%
Shouyao Holdings (Beijing) Co. Ltd. A SHG:688197	Biotechnology	79.48%
Innovita Biological Technology Co. Ltd. A SHG:688253	Biotechnology	70.49%
Sunmax Biotechnology Co Ltd TWO:4728	Biotechnology	10.53%

Annual Asset Resilience Ratio for SK Bioscience Co Ltd (2018–2024)

The table below shows the annual Asset Resilience Ratio data for SK Bioscience Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	29.73%	₩845.41 Billion ≈ $572.92 Million	₩2.84 Trillion ≈ $1.93 Billion	-32.19pp
2023-12-31	61.92%	₩1.15 Trillion ≈ $777.38 Million	₩1.85 Trillion ≈ $1.26 Billion	+3.31pp
2022-12-31	58.62%	₩1.26 Trillion ≈ $850.85 Million	₩2.14 Trillion ≈ $1.45 Billion	-14.73pp
2021-12-31	73.34%	₩1.55 Trillion ≈ $1.05 Billion	₩2.11 Trillion ≈ $1.43 Billion	+40.66pp
2020-12-31	32.68%	₩183.74 Billion ≈ $124.52 Million	₩562.23 Billion ≈ $381.02 Million	+12.85pp
2019-12-31	19.82%	₩80.09 Billion ≈ $54.27 Million	₩403.98 Billion ≈ $273.77 Million	-4.81pp
2018-12-31	24.63%	₩99.19 Billion ≈ $67.22 Million	₩402.71 Billion ≈ $272.91 Million	--

pp = percentage points

About SK Bioscience Co Ltd

KO:302440 Korea Biotechnology

Market Cap

$2.29 Billion

₩3.38 Trillion KRW

Market Cap Rank

#5783 Global

#150 in Korea

Share Price

₩43050.00

Change (1 day)

-1.37%

52-Week Range

₩38800.00 - ₩60100.00

All Time High

₩335500.00